Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
2021 · The Lancet · 1,818 citations
https://doi.org/10.1016/s0140-6736(21)00676-0
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
60
Papers
1.0K
Citations
13
h-index
14
i10-index
James Robertson is an academic researcher. The author has contributed to research in topics: Forensic and Genetic Research & Cystic Fibrosis Research Advances & Radiation Dose and Imaging. The author has an h-index of 13, co-authored 51 publications.
Click to start Chat